Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

CD10 Expression in Cutaneous Squamous Cell Carcinoma and Its Precursor Lesions: Evaluation Using Tissue Microarray.

Yun JH, Roh JY, Park SH, Lee JR.

Ann Dermatol. 2013 Nov;25(4):515-7. doi: 10.5021/ad.2013.25.4.515. Epub 2013 Nov 30. No abstract available.

3.
4.

CD10 is expressed in cutaneous clear cell lesions of different histogenesis.

Perna AG, Smith MJ, Krishnan B, Reed JA.

J Cutan Pathol. 2005 May;32(5):348-51.

PMID:
15811119
6.

Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.

Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, Zhan QM, Taylor PR, Lu N.

BMC Cancer. 2006 Dec 22;6:296.

7.

Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.

de Feraudy S, Mar N, McCalmont TH.

Am J Surg Pathol. 2008 Aug;32(8):1111-22. doi: 10.1097/PAS.0b013e31816b8fce.

PMID:
18545147
8.

CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.

Wagoner J, Keehn C, Morgan MB.

Am J Dermatopathol. 2007 Dec;29(6):555-8.

PMID:
18032951
9.

The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.

Wieland CN, Dyck R, Weenig RH, Comfere NI.

J Cutan Pathol. 2011 Nov;38(11):884-8. doi: 10.1111/j.1600-0560.2011.01768.x. Epub 2011 Aug 23.

PMID:
21883368
10.

Expression of CD10 in basal cell carcinoma.

Yada K, Kashima K, Daa T, Kitano S, Fujiwara S, Yokoyama S.

Am J Dermatopathol. 2004 Dec;26(6):463-71.

PMID:
15618927
11.

CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.

Omran OM.

J Environ Pathol Toxicol Oncol. 2012;31(3):203-12.

PMID:
23339695
12.
13.

CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.

Gürel D, Kargı A, Karaman I, Onen A, Unlü M.

Pathol Oncol Res. 2012 Apr;18(2):153-60. doi: 10.1007/s12253-011-9421-8. Epub 2011 Jun 18.

PMID:
21681600
14.

CD10 expression in stromal cells of oral cavity squamous cell carcinoma: a clinic and pathologic correlation.

Piattelli A, Fioroni M, Iezzi G, Perrotti V, Stellini E, Piattelli M, Rubini C.

Oral Dis. 2006 May;12(3):301-4.

PMID:
16700740
15.
16.

Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions.

Abbas O, Richards JE, Yaar R, Mahalingam M.

Mod Pathol. 2011 Jan;24(1):90-7. doi: 10.1038/modpathol.2010.180. Epub 2010 Sep 17.

17.
18.

p16INK4a expression in actinic keratosis and Bowen's disease.

Salama ME, Mahmood MN, Qureshi HS, Ma C, Zarbo RJ, Ormsby AH.

Br J Dermatol. 2003 Nov;149(5):1006-12.

PMID:
14632806
19.
20.

Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.

de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM.

Am J Surg Pathol. 2001 Jun;25(6):732-41.

PMID:
11395550
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk